Access publications from members of the CART-GRAC network:

Dr. Wendy V. Norman: “WV Norman – PubMed”

Dr. Sarah Munro: “S Munro – PubMed”

Dr. Sheila Dunn: “Dunn S – PubMed”

Dr. Édith Guilbert: “ER Guilbert – PubMed”

Dr. Regina-Maria Renner: “RM Renner – PubMed”

Dr. Abdul-Fatawu Abdulai: “AF Abdulai – PubMed”

Dr. Laura Schummers: “L Schummers – PubMed”

Dr. Elizabeth Darling: “EK Darling – PubMed”

Dr. Martha Paynter: “M Paynter – PubMed”

Dr. Melissa Brooks: “M Brooks – PubMed”

Dr. Stephanie Begun: “S Begun – PubMed”

Dr. Helen Pymar: “H Pymar – PubMed”

Dr. Sabrina Lee: “Lee SC – PubMed”



Renner, R. M., Ennis, M., Maazi, M., Dunn, S., Norman, W. V., Kaczorowski, J., & Guilbert, E. (2023). Development and pilot testing of the 2019 Canadian Abortion Provider Survey. Pilot and feasibility studies9(1), 49.

Carson, A., Stirling-Cameron, E., Paynter, M., Munro, S., Norman, W. V., Kilpatrick, K., Begun, S., & Martin-Misener, R. (2023). Barriers and enablers to nurse practitioner implementation of medication abortion in Canada: A qualitative studyPloS one18(1), e0280757.

Renner, R. M., Hu, V., Guilbert, É. R., Albert, A. Y. K., White, K. O., Jones, H. E., Guan, X., & Norman, W. V. (2023). First-trimester surgical abortion practice in Canada in 2012. Canadian family physician Medecin de famille canadien69(1), 36–44.

Carson A, Cameron ES, Paynter M, Norman WV, Munro S, Martin-Misener R. (2023). Nurse practitioners on ‘the leading edge’ of medication abortion care: A feminist qualitative approach. J Adv Nurs. 2023;79(2):686-697. doi:10.1111/jan.15487



Munro, S. B., Dunn, S., Guilbert, E. R., & Norman, W. V. (2022). Advancing Reproductive Health through Policy-Engaged Research in Abortion Care. Seminars in reproductive medicine40(5-06), 268–276.

Paynter, M. J., & Norman, W. V. (2022). The Intersection of Abortion and Criminalization: Abortion Access for People in Prisons. Seminars in reproductive medicine40(5-06), 264–267.

Zusman, E. Z., Munro, S., Norman, W. V., & Soon, J. A. (2022). Pharmacist direct dispensing of mifepristone for medication abortion in Canada: a survey of community pharmacists. BMJ open12(10), e063370.

Lee, S. C., & Norman, W. V. (2022). Emergency contraception subsidy in Canada: a comparative policy analysis. BMC health services research22(1), 1110.

Carson, A., Paynter, M., Norman, W. V., Munro, S., Roussel, J., Dunn, S., Bryant-Lukosius, D., Begun, S., & Martin-Misener, R. (2022). Optimizing the Nursing Role in Abortion Care: Considerations for Health EquityNursing leadership (Toronto, Ont.)35(1), 54–68.

Schummers, L., Darling, E. K., Dunn, S., McGrail, K., Gayowsky, A., Law, M. R., Laba, T. L., Kaczorowski, J., & Norman, W. V. (2022). Abortion Safety and Use with Normally Prescribed Mifepristone in Canada. The New England journal of medicine386(1), 57–67.



Schummers, L., Oveisi, N., Ohtsuka, M. S., Hutcheon, J. A., Ahrens, K. A., Liauw, J., & Norman, W. V. (2021). Early pregnancy loss incidence in high-income settings: a protocol for a systematic review and meta-analysisSystematic reviews10(1), 274.

Ennis, M., Wahl, K., Jeong, D., Knight, K., Renner, R., Munro, S., Dunn, S., Guilbert, E., & Norman, W. V. (2021). The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemicFamily practice38(Suppl 1), i30–i36.

Gormley, R., Vickers, B., Cheng, B., & Norman, W. V. (2021). Comparing options for females seeking permanent contraception in high resource countries: a systematic review. Reproductive health18(1), 154.

Rebic, N., Munro, S., Norman, W. V., & Soon, J. A. (2021). Pharmacist checklist and resource guide for mifepristone medical abortion: User-centred development and testing. Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC154(3), 166–174.

Jia, L., & Norman, W. V. (2021). Contraception Practices Among Women on Opioid Agonist Therapy. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC43(2), 204–210.



Schummers L. Interpregnancy interval and severe maternal morbidity – What can we learn from vital records data? Paediatr Perinat Epidemiol. 2020;34:388–391.

Bateson DJ, Lohr PA, Norman WV, Moreau C, Gemzell-Danielsson K, Blumenthal PD, Hoggart L, Li HWR, Aiken A, Black K. The impact of COVID-19 on contraception and abortion care policy and practice: experiences from selected countries. BMJ Sexual & Reproductive Health. 2020; Online First, 2020 Aug 10.

Munro S, Guilbert E, Wagner MS, Wilcox ES, Devane C, Dunn S, Brooks M, Soon JA, Mills M, Leduc-Robert G, Wahl K, Zannier E, Norman WV. Perspectives on factors influencing implementation of mifepristone medical abortion among Canadian physicians: a national qualitative study. Annals of Family Medicine. 2020;18(5):413-21.

Schummers L, Hutcheon JA, Norman WV, Liauw J, Bolatova T, Ahrens KA. Short interpregnancy interval and pregnancy outcomes: How important is the timing of confounding variable ascertainment? Paediatric and Perinatal Epidemiology. 2020 Dec 3.

Norman WV, Munro S. Let’s keep our eye on the ball! Safety is important as pandemic conditions advance telemedicine abortion, but patient experience is also key. BMJ Sexual & Reproductive Health. 2020;46(3):159-60.

Jia L, Norman WV. Contraception Practices among Women on Opioid Agonist Therapy. Journal of Obstetrics and Gynaecology Canada. Online first 2020 Aug 3.

Wagner M-S, Munro S, Wilcox ES, Devane C, Norman WV, Dunn S, Soon JA, Guilbert E. Barriers and facilitators to the implementation of first trimester medical abortion with mifepristone in the province of Quebec: a qualitative investigation. JOGC. 2020 May;42(5):576-582. doi: 10.1016/j.jogc.2019.10.037.

Guilbert ER, Wagner M-S, Munro S, Wilcox ES, Dunn S, Soon JA, Devane C, Norman WV. Slow Implementation of Mifepristone Medical Termination of Pregnancy in Quebec, Canada: A qualitative investigation. European Journal of Contraception & Reproductive Health Care. 2020 Jun;25(3):190-198. doi: 10.1080/13625187.2020.1743825. Epub 2020 Apr 21. PMID: 32312130.

Dineley B, Munro S, Norman WV. Leadership for Success in Transforming Medical Abortion Policy in Canada. PLOS ONE. 2020 Jan 8;15(1):e0227216. doi: 10.1371/journal.pone.0227216.

Shaw D, Norman WV. When there are no abortion laws: A case study of Canada. Best Practice & Research Clinical Obstetrics & Gynaecology. 2020 Jan;62(1):49-62.; pii: S1521-6934(19)30055-0. doi: 10.1016/j.bpobgyn.2019.05.010. [Epub ahead of print 2019 May 25]



Shaw D, Norman WV. When there are no abortion laws: A case study of Canada. [Review]. Best practice & research. Clinical obstetrics & gynaecology. 2019 May 25.

Gill R, Ogilvie G, Norman WV, Fitzsimmons B, Maher C, Renner R. Feasibility and Acceptability of a Mobile Technology Intervention to Support Postabortion Care in British Columbia: Phase I. Journal of Medical Internet Research. 21(5):e13387. 2019 May 29.

Burk JC; Norman WV. Trends and determinants of postabortion contraception use in a Canadian retrospective cohort. Contraception. 100(2):96-100, 2019 Aug.

McLaren L; Braitstein P; Buckeridge D; Contandriopoulos D; Creatore MI; Faulkner G; Hammond D; Hoffman SJ; Kestens Y; Leatherdale S; McGavock J; Norman WV; Nykiforuk C; Ridde V; Smylie J. Why public health matters today and tomorrow: the role of applied public health research. Canadian Journal of Public Health. Revue Canadienne de Sante Publique. 110(3):317-322, 2019 Jun.

Norman WV; Munro S; Brooks M; Devane C; Guilbert E; Renner R; Kendall T; Soon JA; Waddington A; Wagner MS; Dunn S. Could implementation of mifepristone address Canada’s urban-rural abortion access disparity: a mixed-methods implementation study protocol. BMJ Open. 9(4):e028443, 2019 Apr 20.

Gormley R; Vickers B; Norman WV. Comparing options for women seeking permanent contraception in high-resource countries: a protocol for a systematic review. Systematic Reviews. 8(1):74, 2019 Mar 26.

Workman M; Albert AYK; Norman WV. Training family physicians as researchers: Outcomes over 15 years for Canada’s first clinician scholar program. Canadian Family Physician. 65(1):45-51, 2019 Jan.

Dunn S; Xiong AQ; Nuernberger K; Norman WV. Non-use of Contraception by Canadian Youth Aged 15 to 24: Findings From the 2009-2010 Canadian Community Health Survey. Journal of Obstetrics & Gynaecology Canada: JOGC. 41(1):29-37, 2019 Jan.

Al-Imari L; Hum S; Krueger P; Dunn S. Breastfeeding During Family Medicine Residency.Family Medicine. 51(7):587-592, 2019 Jul.

Warden S; Genkin I; Hum S; Dunn S. Outcomes During Early Implementation of Mifepristone-Buccal Misoprostol Abortions up to 63 Days of Gestation in a Canadian Clinical Setting. Journal of Obstetrics & Gynaecology Canada: JOGC. 41(5):647-652, 2019 May.

Gagliardi AR; Dunn S; Foster A; Grace SL; Green CR; Khanlou N; Miller FA; Stewart DE; Vigod S; Wright FC. How is patient-centred care addressed in women’s health? A theoretical rapid review. BMJ Open. 9(2):e026121, 2019 Feb 13.



Costescu D, Guilbert E, Bernardin J, Black A, Dunn S, Gomes M, Fitzsimmons B, McNamara L, Norman WV, Renner R, Trouton K, Wagner MS. Induced Abortion: Surgical Abortion and Second Trimester Medical Methods. SOGC Clinical Practice Guideline. J Obstet Gynaecol Can. 2018 June;40(6):750-83.



Henning PA, Burgess, CK Jones, HE, Norman WV. The effects of asking a fertility intention question in primary care settings: a systematic review protocol. Syst Rev. 2017 Jan 19;6(1):11.

Asgharpour M, Villareal S, Schummers L, Hutcheon J, Shaw D, Norman, WV. Inter-pregnancy interval and pregnancy outcomes among women with delayed childbearing: Protocol for a systematic review. Syst Rev. 2017 Apr 8;6(1):75.

Black A, Guilbert E, Costescu, D, Dunn S, Fisher W, Kives S, Mirosh M, Norman WV, et al. Canadian Contraception Consensus Guidelines No. 329-(Part 4 of 4) Chapter 9: Combined Hormonal Contraception). J Obstet Gynaecol Can 2017 Apr;39(4): 269-314.e5.

Norman WV, Dickens BM. Abortion by telemedicine: An equitable option for Irish women. BMJ 2017 May 16: 357: J2237.



Guilbert ER, Hayden A, Jones HE, O’Connell White K, Lichtenberg ES, Paul M, Norman WV. First trimester medical abortion practices in Canada: A national survey. Can Fam Physician 2016 Apr;62(4):e201-8.

Norman WV, Guilbert ER, Okpaleke C, Hayden A, Lichtenberg ES, Paul M, O’Connell White K, Jones HE. Abortion health services in Canada: a 2012 national survey. Can Fam Physician 2016 Apr 62(4):e209-17.

Black A, Guilbert E, Costescu, D, Dunn S, Fisher W, Kives S, Mirosh M, Norman WV, et al. Canadian Contraception Consensus Guidelines No. 329, (Part 3 of 4: Chapter 7). J Obstet Gynaecol Can 2016 Feb;38(2):182-222.

Black A, Guilbert E, Costescu, D, Dunn S, Fisher W, Kives S, Mirosh M, Norman WV, et al. Canadian Contraception Consensus Guidelines No. 329, (Part 3 of 4: Chapter 8). J Obstet Gynaecol Can 2016 Mar;38(3):279-300.

Costescu D, Guilbert E, Bernardin J, Black A, Dunn S, Fitzsimmons B, Norman WV, Pymar H, Soon J, Trouton K, Wagner MS, Wiebe E. Medical Abortion. SOGC Clinical Practice Guideline. J Obstet Gynaecol Can. 2016 Apr;38(4):366-89.

Samiedaluie S, Peterson S, Brant R, Kaczorowski J, Norman WV. Validating abortion procedure coding in British Columbia administrative database. BMC Health Services Research 2016 16:255.

Wong E, Leslie JJT, Soon JA, Norman WV. Measuring interprofessional competencies and attitudes among health professional students creating family planning virtual patient cases. BMC Medical Education 2016 Oct 19;16(1):273.

Troskie C, Soon J, Albert A, Norman, WV. Regulatory approval time for hormonal contraception in Canada, the United States and the United Kingdom, 2000-2015: a retrospective data analysis. CMAJ Open. 2016 Nov 3. 4:4.



Norman WV. Our struggle to implement best practices: the example of antibiotic prescription for respiratory tract infection. Family Practice 2015 Aug;32(4):365-366.

Hulme J, Dunn S, Guilbert E, Soon JA, Norman WV. Barriers and facilitators to family planning access in Canada: stakeholder input on implications for health system and policy reform. Healthcare Policy 2015 Feb;10(3):48-63.

Asgharpour M, Villarreal S, Shummers L, Hutcheon J, Shaw D, Norman WV. What is the relationship between inter-pregnancy interval and maternal and perinatal outcomes among women who delayed childbearing to 30 years or older? PROSPERO 2015 June: CRD42015019057

Henning P, Burgess C, Jones HE, Norman WV. Systematic review of the effects of asking reproductive intention questions in primary care settings. PROSPERO 2015 July: CRD42015019726

Norman WV, Stothart D. IUD string perforation through anterior cervix: A case report. J Obstet Gynaecol Can 2015;37(4):345–348. FA, SA

Black A, Guilbert E, Costescu, D, Dunn S, Fisher W, Kives S, Mirosh M, Norman WV, et al. Canadian Contraception Consensus Guidelines No. 329, (Part 1 of 4). J Obstet Gynaecol Can 2015 Oct;37(10): 936-42, S1-S28.

Black A, Guilbert E, Costescu, D, Dunn S, Fisher W, Kives S, Mirosh M, Norman WV, et al. Canadian Contraception Consensus Guidelines No. 329, (Part 2 of 4). J Obstet Gynaecol Can 2015 Nov;37(11):1033-5.



Norman WV, Hestrin B, Dueck R. Access to complex abortion care service and planning improved through a toll-free telephone resource line. Obstetrics and Gynecology International, 2014 Feb, Artical ID 913241, 4 pages.

Norman WV, Abi-Jaoudé A, Shaw D, Davies C. Contraception & Abortion in BC: Experience guiding Research guiding Care. Conference Proceedings. Vancouver, BC. May 5th, 2014.

Norman WV. Do you have a secret researcher inside? High-quality family medicine research at Family Medicine Forum. CFP July 2014; 60(7): 602-04.

Caddy S, Yudin MH, Hakim J, Money DM, Norman WV, Allen VM, Bouchard C, Boucher M, Castillo E, Murphy KE, Ogilvie G, Paquet C. Best Practices to Minimize Risk of Infection With Intrauterine Device Insertion. SOGC Infectious Disease Committee Opinion. J Obstet Gynaecol Can 2014; 36(3):266–276.

Wong M, Soon JA, Zed P, Norman WV. Development of a survey to assess acceptability of an innovative contraception practice among rural pharmacists. Pharmacy. 2014; 2(1): 124-136.

Norman WV, Brooks M, Brant R, Soon JA, Majdzadeh A, Kaczorowski J. What proportion of Canadian women will accept an intrauterine contraceptive at the time of second trimester abortion? Recruitment findings of a randomized controlled trial. J Obstet Gynaecol Can. 2014 Jan;36(1):51-9.



Norman WV, Soon JA, Maughn N., Dressler J. Barriers to Rural Induced Abortion Services in Canada: Findings of the British Columbia Abortions Provider Survey (BCAPS). PLOS One 2013 June 28, 8(6): e67023.

Norman WV, Stroulia E, Scott-Parker J, Dunn S. Putting Technology in the Service of Family Planning: Developing Best Practices for Informing the Public and Training Health Professionals. CART-GRAC Proceedings. 2013 Feb 26.

Guy M, Norman WV, Malhotra U. Assessing the Health Care Needs of Women in British Columbia: Development and Validation of a Survey Tool. Can Fam Phys 2013;59 e101-e109.

Norman WV, Stroulia E, Scott-Parker J, Dunn S. Putting Technology in the Service of Family Planning: Developing Best Practices for Informing the Public and Training Health Professionals. CART-GRAC Proceedings. 2013 Feb 26.

MacDonald K, Norman WV, Popescu O. New Anomalies due to Methotrexate and Misoprostol Exposure in Early Pregnancy. International Journal of Gynecology and Obstetrics; 2013; 122(3): 267-268.

Dressler J., Maughn N., Soon JA, Norman WV. The Perspective of Rural Physicians Providing Abortion In Canada: Qualitative Findings of the BC Abortion Providers Survey (BCAPS). PLOS One 2013 June 28, 8(6): e67070.



Norman WV. Chiles JL, Turner CA, Brant R, Aslan A, Kaczorowski J. Comparing effectiveness of Copper Intrauterine Devices available in Canada: Is FlexiT non-inferior to NovaT when inserted immediately following first-trimester abortions? A study protocol for a randomized controlled trial. BMC Trials 2012: 147-162.

Norman WV, Dunn S, Guilbert E, Soon J, Hutchison P. Developing a National Family Planning Primary Healthcare Research Program: opportunities and priorities identified through stakeholder and expert consultations. Toronto, Ontario. March 2012.

Ames CM, Norman WV. Preventing repeat abortion: is the immediate insertion of intrauterine devices post-abortion a cost effective intervention associated with fewer repeat abortions in a Canadian population? Contraception, 2012; 85(1): 51-55.

Norman WV. Induced abortion in Canada 1974-2005: Trends over the first generation with legal access. Contraception. 2012 Feb;85(2):185-91.

Norman WV. Metronidazole prophylaxis prior to surgical abortion: Retrospective review of 51,330 cases. J Obstet Gynaecol Can 2012; 34(7): 648–652.


Articles available online: 

2011 and prior

Montgomery CA, Norman WV, Money DM, Rekart ML. Antibiotic Prophylaxis at the time of Induced Abortion. BCMJ September 2002;44 (7):367-373

Norman WV, Kaczorowski J, Soon JA, Brant R, Bryan S, Trouton K, Dicus J. Immediate vs. Delayed Insertion of Intrauterine Contraception after Second Trimester Abortion: Protocol and Rationale for a Randomized Controlled Trial. Trials 2011, 12:149.

Norman WV, Shoveller JA, Kaczorowski J. Contraception & Abortion in BC: Experience guiding Research guiding Care. Conference proceedings. Richmond BC, April 28th , 2011

Cessford TA, Norman WV. Making a case for abortion curriculum reform: A knowledge assessment survey of undergraduate medical students. J Obstet Gynaecol Can 2011; 33(1): 38–45.

Norman WV, Bergunder J, Eccles L. Accuracy of Gestational Age Estimated by Menstrual Dating in Women Seeking Abortion Beyond Nine Weeks. J Obstet Gynaecol Can 2011;33(3):252–257.